Laboratoires Biové SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Laboratoires Biové SA - overview
Location
-, -, France
Primary Industry
Pharmaceuticals
About
Laboratoires Biové SA is a France-based company that operates as a manufacturer and provider of veterinary medicines.
Current Investors
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.biove.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Laboratoires Biové SA - timeline of key events
Laboratoires Biové SA - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 28,746,559 | 26,769,641 | 29,090,379 | 30,430,869 | 30,326,728 | 32,573,419 | - | - | - |
| % Revenue Growth (YoY) | - | (6.9%) | 8.7% | 4.6% | (0.3%) | 7.4% | - | - | - |
| EBITDA (USD) | 3,929,202 | 2,426,042 | 2,290,051 | 2,211,237 | 2,179,144 | 2,344,966 | - | - | - |
| Operating Income (USD) | 3,720,113 | 2,186,001 | 2,023,426 | 1,869,578 | 1,792,879 | 1,852,142 | - | - | - |
| Operating Margin | 12.9% | 8.2% | 7.0% | 6.1% | 5.9% | 5.7% | - | - | - |
| % EBITDA Margin | 13.7% | 9.1% | 7.9% | 7.3% | 7.2% | 7.2% | - | - | - |
| NET Income (USD) | 2,090,307 | 1,599,224 | 1,368,740 | 1,045,850 | 1,297,239 | 1,173,082 | - | - | - |
| % Net Margin | 7.3% | 6.0% | 4.7% | 3.4% | 4.3% | 3.6% | - | - | - |
Laboratoires Biové SA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.